SUGAR LAND--May 18, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Virtually every region of North America has a portion of the $30 billion worth of capital projects already in construction for the Pharmaceutical-Biotech Industry. A recent survey of Industrial Info's database revealed 416 North American pharma-bio projects with a cumulative total investment value (TIV) of $30.29 billion that are under construction.

Within this article: Lists projects underway developed by companies such as Baxalta (NYSE:BXLT), Procter & Gamble Company (NYSE:PG) and Johnson & Johnson's (NYSE:JNJ) (New Brunswick, New Jersey. Additional companies: Fluor Corporation (NYSE:FLR)